Self-estimation of phenylketonuria patients on therapeutic diet. Psychological support

Kostas Konstantinos Iakovou; Kleopatra Schulpis

doi:10.1515/dmpt-2020-0107

Article

Self-estimation of phenylketonuria patients on therapeutic diet. Psychological support

Kostas Konstantinos Iakovou and Kleopatra Schulpis

Published/Copyright: June 30, 2020

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

From the journal Drug Metabolism and Personalized Therapy Volume 35 Issue 2

Abstract

Objectives

Self-esteem is the degree to which the qualities and characteristics contained in one’s self-concept are perceived to be positive. The aim of this study was to evaluate the self-esteem scores in phenylketonuria (PKU) patients on “strict”, “loos” and “off diet”. Sixty PKU patients were divided in three equal groups.

Methods

Group a: “on strict”, group b: “on loos” and group c: “off diet”. A special questionnaire for self-esteem scores was created for these patients.

Results

Before psychological support, group a patients demonstrated 6/20 (30%) very high self-esteem, 9/20 (45%) high and 5/25 (25%) moderate. After support 14/20 (70%) were turned to very high, 5/20 (25%) represented high except one whose degrees remained an altered. group b 4/20 (20%) were very high, 7/20 (35%) were high, 3/20 (15%) moderate and the rest of them showed low self-esteem degrees, after support, 10/20 (50%) showed very high, 5/20 (25%) became high, 3/20 (15%) turned to moderate and 2/20 (10%) remained unaltered. Group c, 1/20 (5%) were very high self-esteemed, 7/20 (35%) were high, 6/20 (30%) were moderate and 6/20 (30%) with low self-esteemed, at the end of support, 6/20 (30%) become very high, 8/20 (40%) with high, 4/20 (20.0%), moderate self-esteem whereas the rest were unaltered.

Conclusions

Very high and high self-esteem degrees were demonstrated in patients who follow their PKU diet. Moderate and low self-esteem degrees were predominantly found in patients on loos and or off diet. Psychological supports commonly result in amelioration of self-esteem degrees.

Keywords: antiepileptics; child chronic illness; child support and mental health; drug metabolism; metabolic disorders; pharmacogenetics

Corresponding author: Kostas Konstantinos Iakovou, Institute of child health, Inborn Errors of Metabolism, Hivon & Papadiamantopoulou, 15773, Αthens, 11527, Attiki, Greece, Phone: 0030210-7467790; Fax: 0030210-7700111, E-mail: iakovoukostas@hotmail.com

Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Ethical approval: The study was in accordance to the Helsinki declaration (1980) and (1983) as revised in 2013, and was approved by the local Ethics Committee.

References

1. Brumm, VI, Bilder, D, Waisbren, SE. Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metabol 2010;99:S59–63. https://doi.org/10.1016/j.ymgme.2009.10.182.Search in Google Scholar PubMed

2. World Health Organization. The role of WHO in public health. Geneva: World Health Organization [accessed 19 April 2011].Search in Google Scholar

3. Iakovou, K, Schulpis, K. The beneficial effect of psychological support on PKU patients with depression. Int J Adolesc Med Health. [PUBMED].Search in Google Scholar

4. Shulpis, K, Iakovou, K. Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress. J Pediatr Endocrinol Metab 2019;32:791–5. https://doi.org/10.1515/jpem-2019-0109.Search in Google Scholar PubMed

5. Vockley, J, Anderson, HC, Antshel, KM, Braverman, NE, Burton, BK, Frazier, DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 2014; 16:188–200. https://doi.org/10.1038/gim.2013.157.Search in Google Scholar PubMed

6. World Health Organization. Prevention and promotion in mental health. Geneva: WHO; 2002 Google Scholar.Search in Google Scholar

7. Schulpisa, K, Karakonstantakis, T, Bartzeliotou, A, Karikas, G, Papassotiriou, I. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin nutrition 2004;23 401–7. https://doi.org/10.1016/j.clnu.2003.09.006.Search in Google Scholar PubMed

8. Dittmann, M. Self-esteem that’s based on external sources has mental health consequences, study says; 2002. Available from: https://www.apa.org/monitor/dec02/selfesteem.10.1037/e300122003-014Search in Google Scholar

9. Brummelman, E, Thomaes, S, Orobio de Castro, B, Overbeek, G, Bushman, BJ. “That’s not just beautiful – that’s incredibly beautiful!” : the adverse impact of inflated praise on children with low self-esteem. Psychol Sci 2014;25:728–35. https://doi.org/10.1177/0956797613514251.Search in Google Scholar PubMed

10. Iakovou, K, Madoglou, A, Monopolis, I, Schulpis, K. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living. J Pediatr Endocrinol Metab 2019;32:281–5. https://doi.org/10.1515/jpem-2018-0525.Search in Google Scholar PubMed

11. Ιakovou, K, Schulpis, K. The beneficial effect of psychological support on mothers with PKU children who suffer from social discrimination and damage of quality of life. J Pediatr Endocrinol Metab 2019;32:95–8. https://doi.org/10.1515/jpem-2019-0384.Search in Google Scholar PubMed

12. Ιakovou, K, Schulpis, K. Phenylketonuric patients, who adhere or not to their dietary treatment, suffer from social discrimination and damage of quality of life. J Pediatr Endocrinol Metab 2020 [Production processing].Search in Google Scholar

13. Vallis, M, Bruns, KK, Hollahan, D, Ross, S, Hahn, J. Diabetes attitudes, wishes, and needs second study (DAWN2): understanding diabetes-related psychosocial outcomes for Canadians with diabetes. Can J Diabetes 2016;40:234–41. https://doi.org/10.1016/j.jcjd.2015.11.002.Search in Google Scholar PubMed

14. Corrigan, PW, Watson, AC, Barr, L. The self-stigma of mental illness: implications for self-esteem and self-efficacy. J Soc Clin Psychol 2006;25:875–85. https://doi.org/10.1521/jscp.2006.25.8.875.Search in Google Scholar

15. Clark, NM, Dodge, JA. Exploring self-efficacy as a predictor of disease management. Health Educ Behav 1999;26:72–89. https://doi.org/10.1177/109019819902600107.Search in Google Scholar PubMed

16. Bodenheimer, T, Lorig, K, Holman, H, Grumbach, K. Patient self-management of chronic disease in primary care. J Am Med Assoc 2002;288:2469–75. https://doi.org/10.1001/jama.288.19.2469.Search in Google Scholar PubMed

17. Bandura, A. Health promotion by social cognitive means. Health Educ Behav 2004;31:143–64. https://doi.org/10.1177/1090198104263660.Search in Google Scholar PubMed

18. Poon, S. Pacifica: stressed or worried? An app to help yourself (Mobile App User Guide). Br J Sports Med 2016;50:191–2. https://doi.org/10.1136/bjsports-2015-095747.Search in Google Scholar

19. Collins, G. Language to motivate learning: the power of inspirational quotes. A Rising Tide 2016;7:1–22.Search in Google Scholar

20. Ιakovou, K, Schulpis, K. Phenylketonuric patients socially represent their disease. J Pediatr Endocrinol Metab 2019;32:1217–20. https://doi.org/10.1515/jpem-2019-0253.Search in Google Scholar PubMed

Received: 2020-03-12

Accepted: 2020-04-06

Published Online: 2020-06-30

You are currently not able to access this content.

Articles in the same Issue

https://doi.org/10.1515/dmpt-2020-0107

Keywords for this article

antiepileptics; child chronic illness; child support and mental health; drug metabolism; metabolic disorders; pharmacogenetics